Kohei shitara (@KoheiShitara) / X

Ryan Massa (@RyanCMassa) / X

PD-1 Inhibitors for Advanced Gastroesophageal Cancer

ASCO #GI22: Gastric and esophageal cancers, HER2-targeted therapy, immunotherapy, ADCs

Margherita Ambrosini (@margheambro1) / X

Kohei shitara (@KoheiShitara) / X

Kohei shitara on X: This was fantastic experience at @sloan_kettering. It was also my great pleasure to invite @YJanjigianMD to Japan. Lets keep global collaboration and friendships! / X

Kohei SHITARA, Chief, Department of Gastrointestinal Oncolology

Tyler Mattox, PhD (@temattox) / X

ASCO #GI22: Gastric and esophageal cancers, HER2-targeted therapy, immunotherapy, ADCs

Kohei Shitara, MD, Discusses Immunotherapy in Gastric Cancer at 2022 IGCC